• Skip to primary navigation
  • Skip to main content
  • Skip to primary navigation
  • Skip to main content
Choose which site to search.
UAMS Health Logo UAMS Health
Neonatal Intensive Care Unit (NICU)
  • UAMS.edu
  • MyChart
  • Giving
  • Emergency Room
  • Our NICU
    • Our Clinic
    • Research in the NICU
    • Staying Overnight at the NICU
    • NICU Statistics
    • Communication with Our Staff
    • Staff Roles
    • Visiting the NICU
  • Angel Eye Program
  • Patient Resources
    • UAMS and Arkansas Children’s Hospital
    • Advice From NICU Families
    • NICU Frequently Asked Questions
    • Helpful Books
  • Spanish Resources
  • myChart
  • Get Involved
  • Events
  • News
  1. UAMS Health
  2. Neonatal Intensive Care Unit (NICU)
  3. Our NICU
  4. Research in the NICU

Research in the NICU

Research and Innovations

Our neonatologists, pediatricians, and fellows are engaged in basic science and clinic research projects, with the goal of improving outcomes for premature babies. The neonatology research team at UAMS supports several projects including, but not limited to, the following topics:

  • Bronchopulmonary dysplasia/chronic lung disease of prematurity
  • Necrotizing enterocolitis
  • Patent ductus arteriosus
  • Opioid withdrawal
  • Neonatal resuscitation
  • Quality improvements within the NICU
  • Long-term outcomes in preterm infants

UAMS collaborates with Arkansas Children’s and other institutions across the United States and internationally, and participates in multicenter clinical trials; through this work we are able to offer our NICU patients the most advanced technology and evidence-based approaches to care.

In addition, our research faculty are actively involved in training and mentoring junior investigators, fellow physicians, pediatric residents, and students.

Current Studies

  • The Connection Study: A randomized, double blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of necrotizing enterocolitis (NEC)
  • Pragmatic, Randomized, Blinded Trial to Shorten Pharmacologic Treatment of Newborns with Neonatal Opioid Withdrawal Syndrome (NOWS)
  • A Partially-Blind, Randomized, Controlled, Parallel-Group Dose Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact (SF-RI 1 surfactant for inhalation combined with a dedicated drug delivery system) in Preterm Infants at Risk of Worsening Respiratory Distress Syndrome
  • A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability Profile of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD)
  • POLAR Trial: Positive End-Expiratory Pressure (PEEP) Levels during Resuscitation of Preterm Infants at Birth 
  • DIVA Trial: The Diaphragmatic Initiated Ventilatory Assist
  • PIVOTAL Trial: Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low weight Infants
  • SILDI-SAFE Trial: Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia 

Contact Us

For more information about our clinical research, please contact our research team at: NICUResearch@uams.edu, (501) 296-1389

UAMS Health LogoUAMS HealthUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Notice of Privacy Practices
  • Price Transparency
  • Legal Notices

© 2025 University of Arkansas for Medical Sciences